Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

3 study records (showing up to 30 per record type)

• Systematic review registration CRD42023430836 Registered protocol, no results here: Review Ongoing
  Does the addition of magnesium sulfate enhance ketamine's anesthetic effect? A Systematic Review and Meta-Analysis
  Condition or outcome area: Patients submitted to any kind of surgery
  2023-06-09 · Subject: Magnesium sulfate; Magnesium Sulfate; 7487-88-9; Magnesium sulphate; Magnesium sulfate anhydrous; MgSO4; Magnesium sulfate (1:1); Magnesiumsulfat; Sal Angalis; Sal De sedlitz · open the ingredient record
• Systematic review registration CRD42017075252 Registered protocol, no results here: Review Ongoing
  A meta-analysis of pharmacological neuroprotection in non-cardiac surgery: focus on statins, lidocaine, ketamine, and magnesium sulphate
  Condition or outcome area: All clinical trials on the use of statins, lidocaine, ketamine, and magnesium sulphate in non-cardiac surgery will be included. All clinical trials on other pharmacological treatments and non-cardiac surgery will be excluded. All clinical trials with any pharmacological treatments and cardiac surgery will be excluded as well. The primary outcome will be neuroprotection.
  2017-08-28 · Subject: Mg; Magnesium; 7439-95-4; magnesio; Magnesium metallicum; Magnesium metal; Magnesium turnings; Rieke's active magnesium; Magnesium powder; MFCD00085308 · open the ingredient record
• Systematic review registration CRD42020220359 Registered protocol, no results here: Review Ongoing
  Ketamine versus lithium for suicidal ideation: a meta-analysis
  Condition or outcome area: Ketamine and lithium had been shown to decrease suicidal ideation, which is particularly beneficial in patients at high risk of suicide. Lewitzka et al studied lithium reduces acute suicidal ideation within the first 5weeks of treatment. Samuel et al studied ketamine rapidly reduces suicidal ideation within one day and for up to one week. However, a systematic review comparing the effect of these two drugs treatment to decrease suicide ideation has not yet been conducted.
  2020-12-13 · Subject: Lithium; 7439-93-2; Li; litio; CHEBI:30145; DTXSID5036761; Litium; Lithium Metal; Lithium, metallic; Lithium, elemental · open the ingredient record